The treatment of systemic lupus proliferative nephritis

Marilynn G. Punaro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus (SLE) in childhood affecting more than 80 % of patients. Treatment of this complication has undergone significant evolution in recent years. A series of randomized controlled trials has clarified the role of a variety of immunomodulating regimens including some novel biologic medications. This review touches on the major trials that have influenced practice and shaped current thinking about the treatment of proliferative lupus glomerulonephritis.

Original languageEnglish (US)
Pages (from-to)2069-2078
Number of pages10
JournalPediatric Nephrology
Volume28
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Lupus Nephritis
Systemic Lupus Erythematosus
Randomized Controlled Trials
Therapeutics

Keywords

  • Lupus
  • Mycophenolate mofetil
  • Nephritis
  • Pediatric lupus
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

The treatment of systemic lupus proliferative nephritis. / Punaro, Marilynn G.

In: Pediatric Nephrology, Vol. 28, No. 11, 11.2013, p. 2069-2078.

Research output: Contribution to journalArticle

Punaro, Marilynn G. / The treatment of systemic lupus proliferative nephritis. In: Pediatric Nephrology. 2013 ; Vol. 28, No. 11. pp. 2069-2078.
@article{02f07619d04d49e98c681ae7b01c0ede,
title = "The treatment of systemic lupus proliferative nephritis",
abstract = "Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus (SLE) in childhood affecting more than 80 {\%} of patients. Treatment of this complication has undergone significant evolution in recent years. A series of randomized controlled trials has clarified the role of a variety of immunomodulating regimens including some novel biologic medications. This review touches on the major trials that have influenced practice and shaped current thinking about the treatment of proliferative lupus glomerulonephritis.",
keywords = "Lupus, Mycophenolate mofetil, Nephritis, Pediatric lupus, Systemic lupus erythematosus",
author = "Punaro, {Marilynn G.}",
year = "2013",
month = "11",
doi = "10.1007/s00467-012-2327-1",
language = "English (US)",
volume = "28",
pages = "2069--2078",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - The treatment of systemic lupus proliferative nephritis

AU - Punaro, Marilynn G.

PY - 2013/11

Y1 - 2013/11

N2 - Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus (SLE) in childhood affecting more than 80 % of patients. Treatment of this complication has undergone significant evolution in recent years. A series of randomized controlled trials has clarified the role of a variety of immunomodulating regimens including some novel biologic medications. This review touches on the major trials that have influenced practice and shaped current thinking about the treatment of proliferative lupus glomerulonephritis.

AB - Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus (SLE) in childhood affecting more than 80 % of patients. Treatment of this complication has undergone significant evolution in recent years. A series of randomized controlled trials has clarified the role of a variety of immunomodulating regimens including some novel biologic medications. This review touches on the major trials that have influenced practice and shaped current thinking about the treatment of proliferative lupus glomerulonephritis.

KW - Lupus

KW - Mycophenolate mofetil

KW - Nephritis

KW - Pediatric lupus

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=84885952474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885952474&partnerID=8YFLogxK

U2 - 10.1007/s00467-012-2327-1

DO - 10.1007/s00467-012-2327-1

M3 - Article

VL - 28

SP - 2069

EP - 2078

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 11

ER -